Chicago Partners Investment Group LLC Acumen Pharmaceuticals, Inc. Transaction History

Chicago Partners Investment Group LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 25, 2024	SELL	$2.97 - $4.64 $12,940 - $20,216	-4,357 Reduced 23.79%	13,958 $56,000
Q4 2023 Feb 23, 2024	BUY	$1.86 - $4.48 $8,808 - $21,217	4,736 Added 34.88%	18,315 $70,000
Q3 2023 Oct 26, 2023	BUY	$4.15 - $9.72 $56,352 - $131,987	13,579 New	13,579 $56,000
Q1 2023 Apr 26, 2023	SELL	$3.75 - $6.65 $23,801 - $42,207	-6,347 Reduced 33.98%	12,332 $50,000
Q4 2022 Feb 09, 2023	BUY	$4.81 - $10.17 $36,527 - $77,230	7,594 Added 68.51%	18,679 $100,000
Q3 2022 Nov 09, 2022	BUY	$4.44 - $10.48 $49,217 - $116,170	11,085 New	11,085 $72,000
Q1 2022 May 20, 2022	SELL	$3.91 - $6.73 $70,223 - $120,870	-17,960 Closed	0 $0
Q4 2021 Feb 15, 2022	BUY	$6.54 - $15.31 $20,640 - $48,318	3,156 Added 21.32%	17,960 $92,000
Q3 2021 Nov 12, 2021	BUY	$14.5 - $20.28 $214,658 - $300,225	14,804 New	14,804 $219,000

41.8M

57.7K

749K

Ticker ABOS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,503,100
Market Cap $74.9M
Description
Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for the treatment of Alzheimer's disease. The company focuses on advancing a targeted immunotherapy drug candidate ACU193, a humanized monoclonal antibody that is in Phase I clinical-stage to target soluble amyloid-beta oligomers. Acumen Ph...

Get notified when there are updates to the investment portfolio of Chicago Partners Investment Group LLC, based on Form 13F filings with the SEC.

Stay updated on Chicago Partners Investment Group LLC with notifications on news.